The second annual Iowa AgriTech Accelerator has chosen five start-up companies to participate in its 2018 program. These innovators will spend 100 days in Des Moines, Iowa, working with mentors in the AgTech industry who will help them with their business plan and making contacts that could help with funding, distribution, etc. They will also receive $40,000 in funding from the program’s sponsors.
TEDCO plans to provide funding and business-building programming to entrepreneurs from groups who are often overlooked by investors through a new fund that will begin this fall.
From cofounding Sirius Satellite Radio to launching a biotech company to find a cure for her daughter’s illness, Martine Rothblatt has had so much career success that any one of her accomplishments would be a crowning achievement for another entrepreneur. “I always try to convert a moonshot into an earthshot,” Rothblatt told hundreds at the Forbes Women’s Summit on Tuesday.
Marriott International, the world’s largest hotel chain, on Thursday broke ground on the $600 million project to build a headquarters in downtown Bethesda.
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the world, announces a strategic and long-term manufacturing agreement with Yiling Wanzhou International Pharmaceutical Co., Ltd. for the manufacturing of entecavir and cilostazol. Yiling Wanzhou International Pharmaceutical Co., Ltd. is a subsidiary of Shijiazhuang Yiling Pharmaceutical Co. Ltd. The contracted manufacturing facilities have been inspected by both the U.S. Food and Drug Administration (FDA) and China FDA (CFDA) and operate to strict International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Manufacturing Practice (GMP) standards, which will enable CASI to eventually sell both entecavir and cilostazol in the U.S., China and worldwide markets. Entecavir and cilostazol are part of the 29 abbreviated new drug applications (ANDAs) that CASI acquired from Sandoz in January 2018.
Accenture (NYSE: ACN) has expanded its metro Washington, D.C. innovation hub with the opening today of a new flagship Cyber Fusion Center, located in Arlington’s Rosslyn business district, designed to help organizations apply new techniques and intelligent tools to defend against data breaches and cyberattacks.
The Iowa AgriTech Accelerator recently announced the five AgTech startups selected for the program’s class of 2018.
Based in Des Moines, the accelerator is a mentor-led program that focuses on ag-based technology innovations. This year’s class is the second to go through the 100-day program.
Inky receives series A funding to enhance analytics capabilities of the software and expand sales and marketing.
Inky Technology Corporation, the leading email security company based in Rockville, Maryland, announces today that ClearSky Security led the Series A round to invest $5.6 million to enhance analytics capabilities of the software and expand sales and marketing. Gula Tech Adventures also participated in the round, and Blackstone (NYSE:BX) has joined as a strategic investor. ClearSky Security Managing Director Peter Kuper has joined CEO/founder Dave Baggett, co-founder Simon Smith, and The Kroger Co. (NYSE: KR) CIO Chris Hjelm on the company’s board of directors.
Host: UM BioPark & Wexford Science + Technology
Location: UM BioPark On the Nook Cafe Patio 801 W. Baltimore Street Baltimore Maryland 21201
Date: June 28, 2018, 5:00pm to 6:30pm
Mingle with BioPark tenants, our UM Ventures staff, UMB faculty and leaders in Baltimore’s technology community. On the Nook Patio, weather permitting.
Today the National League of Cities (NLC) announced a new program, City Innovation Ecosystems, dedicated to helping cities thrive in the modern economy. The program marks a major new push by NLC to support regional entrepreneurship, innovation and STEM pathways in a time when too few cities are fully participating in the high-tech, global economy.
